ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 128 • 2018 ACR/ARHP Annual Meeting

    Inhibition of Prolyl-tRNA Synthetase As a Novel Therapeutic Target for Systemic Sclerosis

    Caroline H. Lee1, Seong-Jin Yoon1, Minjae Cho1, Joon Seok Park2, Yena Kim3, Ji Hyeon Ju4, Da-Jeong Bae5, Choon-Sik Park5, Jong Hyun Kim6, Sunghoon Kim6 and Bongyong Lee1, 1Daewoong Pharmaceuticals, Seoul, Korea, Republic of (South), 2Daewoong pharmaceutical, Seoul, Korea, Republic of (South), 3Catholic iPSC Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 4Division of Rheumatology, Department of Internal Medicine,, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South), 5Division of Allergy and Respiratory Medicine, Soonchunhyang University Bucheon Hospital, Seoul, Korea, Republic of (South), 6Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea, Republic of (South)

    Background/Purpose: Prolyl-tRNA synthetase (PRS), a member of aminoacyl tRNA synthetases (ARS), is an enzyme that conjugates amino acid proline to its tRNA to generate prolyl-tRNA…
  • Abstract Number: 129 • 2018 ACR/ARHP Annual Meeting

    Rnaseq Analysis of Human Skin in Organ Culture Identifies Collagen 22A1 As a TGF-β Early Response Gene

    Tomoya Watanabe1, Logan Mlakar2, Jonathan Heywood3, Willian da Silveira4, Gary Hardiman5 and Carol A. Feghali-Bostwick6, 1Rheumatology, Medical University of South Carolina, Charleston, SC, 2Medical University of South Carolina, Charleston, SC, 3Rheumataology, Medical University of South Carolina, Chareston, SC, 4Center for Genomic Medicine, Medical University of South Carolina, Charleston, SC, 5Department of Medicine, Medical University of South Carolina, Charleston, SC, 6Department of Medicine, Medical University of South Carolina, Division of Rheumatology and Immunology, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc) is a complex multi-system autoimmune disease characterized by immune dysregulation, vasculopathy, and organ fibrosis. Skin fibrosis causes high morbidity and impaired…
  • Abstract Number: 130 • 2018 ACR/ARHP Annual Meeting

    The Role of Cofilin, an Actin Associated Protein, in Activation of Systemic Sclerosis Vascular Smooth Muscle Cells

    Shadia Nada, Bashar Kahaleh and Nezam Altorok, Medicine/Rheumatology, University of Toledo, Toledo, OH

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by activation of the immune system, vascular dysfunction and tissue fibrosis. Vascular dysfunction in…
  • Abstract Number: 131 • 2018 ACR/ARHP Annual Meeting

    Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis

    Paola Di Benedetto1, Rebecca Ross2, Paola Cipriani1, Filomena Esteves3, Vasiliki Liakouli1, Piero Ruscitti1, Francesco Carubbi1, Onorina Berardicurti1, Noemi Panzera1, Salvatore Di Bartolomeo1, Chiara Galloni4, Georgia Mavria4, Francesco Del Galdo2 and Roberto Giacomelli1, 1Department of Applied Clinical Sciences and Biotechnology, Rheumatology Unit, University of L'Aquila, L'Aquila, Italy, 2Leeds Biomedical Research Centre and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 3Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom, 4Signal Transduction and Tumour Microenvironment Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, Italy

    Background/Purpose: Microvascular rarefaction and tissue fibrosis are the hallmarks of Systemic Sclerosis (SSc). CD248, also known as endosialin, is a transmembrane glycoprotein expressed on key…
  • Abstract Number: 132 • 2018 ACR/ARHP Annual Meeting

    Novel Therapeutic Peptides Which Target CD206 Inhibit Macrophage Dependent Fibroblast Activation in Scleroderma

    Bahja Ahmed Abdi1, Henry Lopez2, George Martin3, Charles Garvin3, Jesse Jaynes3, James Stanway4, Christopher P. Denton5, David Abraham6, Shivanee Vigneswaran7, Sian Morris7 and Richard J Stratton8, 1Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 2Murigenics, Vallejo, CA, 3Riptide Bioscience, Vallejo, CA, 4Centre for Rheumatology and Connective Tissue diseases, University College London, London, United Kingdom, 5UCL Division of Medicine, Royal Free Campus, London, United Kingdom, 6Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, 7Centre for Rheumatology and Connective Tissue Diseases, University College London, London, United Kingdom, 8Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom

    Background/Purpose: Alternatively activated macrophages expressing CD206 are believed to promote fibrosis in a range of disorders including systemic sclerosis (SSc). Novel therapeutic peptides (RP) which…
  • Abstract Number: 133 • 2018 ACR/ARHP Annual Meeting

    GBR830, a True OX40 Antagonist Antibody with Potent Suppressive Effects on T Cell-Mediated Pathological Responses

    Julie Macoin1, Stanislas Blein1, Thierry Monney1, Pavankumar Sancheti2, Venkateshwar Reddy3 and Jonathan Back1, 1Glenmark Pharmaceuticals SA, La Chaux-de-Fonds, Switzerland, 2Glenmark Pharmaceuticals Ltd, Mumbai, India, 3Glenmark Pharmaceuticals SA, Paramus, NJ

    Background/Purpose: OX40 (TNFRSF4, CD134) is a costimulatory receptor member of the NGFR/TNFR superfamily expressed predominantly on activated T lymphocytes. Ligation of OX40 by its ligand…
  • Abstract Number: 134 • 2018 ACR/ARHP Annual Meeting

    Exploration of T-Cell Signatures Following TCR Stimulation Using Single Cell RNA-Seq to Inform Treatment Response Studies in Rheumatoid Arthritis

    Paul Martin1, James Ding1, Ben Mulhearn1, Sebastien Viatte1 and Stephen Eyre1,2, 1Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, United Kingdom

    Background/Purpose: For rheumatoid arthritis (RA), as with many other rheumatic diseases, the importance of determining which therapy will work best, early in disease, to prevent…
  • Abstract Number: 135 • 2018 ACR/ARHP Annual Meeting

    High Dimensional Analysis By Mass Cytometry and RNA-Sequencing Reveals Altered Frequency and Exhausted Features of CD4 T and MAIT Cells in Systemic Sclerosis

    Bhairav Paleja1, Andrea Hsiu Ling Low2, Pavanish Kumar1, Suzan Saidin1, Ahmad Lajam2, Camillus Chua3, Liyun Lai1 and Salvatore Albani4, 1Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore, Singapore, 2Singapore General Hospital, Singapore, Singapore, 3Translational Immunology Institute, Singhealth/Duke-NUS Academic Medical Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 4Translational Immunology Institute, Singhealth/Duke-NUS Acedemic Medical Centre, Singapore, Singapore

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterised by excessive fibrosis of skin and internal organs, and vascular dysfunction. Association of T and B…
  • Abstract Number: 136 • 2018 ACR/ARHP Annual Meeting

    Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Disease in Multiple Mouse Models of Autoimmunity

    Stacey Dillon1, Katherine Lewis1, Lawrence Evans2, Ryan Swanson2, Jing Yang3, Martin Wolfson4, Michelle Seaberg1, Kayla Susmilch5, Sherri Mudri1, Mark Rixon4, Stanford Peng6 and Kristine Swiderek7, 1Translational Sciences, Alpine Immune Sciences, Seattle, WA, 2Immunology, Alpine Immune Sciences, Seattle, WA, 3Clinical, R&D, Alpine Immune Sciences, SEATTLE, WA, 4Protein Therapeutics, Alpine Immune Sciences, Seattle, WA, 5Translational Sciences, Alpine Immune Sciences, SEATTLE, WA, 6Clinical, R&D, Alpine Immune Sciences, Seattle, WA, 7Research, Alpine Immune Sciences, SEATTLE, WA

    Background/Purpose: CD28 and Inducible T-cell Costimulator (ICOS) are two related costimulatory molecules within the immunoglobulin superfamily (IgSF) expressed on T cells and interacting with CD80/CD86…
  • Abstract Number: 137 • 2018 ACR/ARHP Annual Meeting

    Autoantibody-Inducing CD4 T (aiCD4 T) Cells Which Induce Systemic Lupus Erythematosus (SLE) Contain Follicular Helper T Cell in Addition to the Major IL-21-Producing CXCR5-ICOShiPD1hi Population: Self-Organized Criticality Theory As the Cause of SLE

    Ken Tsumiyama and Shunichi Shiozawa, Institute for Rheumatic Diseases, Nagahama, Japan

    Background/Purpose: We have shown that repeated immunization with antigen induces systemic lupus erythematosus (SLE) in the mice otherwise not prone to spontaneous autoimmune diseases. We…
  • Abstract Number: 138 • 2018 ACR/ARHP Annual Meeting

    Distinct Roles of Tfh2, SLAMF7+ Tfh1 Cells and Th1 Cells in the Pathogenesis of IgG4-RD

    Kazuhiko Higashioka1, Masahiro Ayano1, Yasutaka Kimoto2, Hiroki Mitoma1, Mitsuteru Akahoshi1, Yojiro Arinobu1, Koichi Akashi1, Takahiko Horiuchi3 and Hiroaki Niro4, 1Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan, 3Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 4Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

    Background/Purpose: IgG4-related disease (IgG4-RD) is a novel disease entity characterized by the infiltration of IgG4-secreting plasmablasts (PBs) and the generation of germinal centers in various…
  • Abstract Number: 139 • 2018 ACR/ARHP Annual Meeting

    Calcium/Calmodulin-Dependent Protein Kinase 4 Promotes GLUT1-Dependent Glycolysis in Systemic Lupus Erythematosus

    Tomohiro Koga1, Masataka Umeda2, Yushiro Endo3, Toshimasa Shimizu2, Remi Sumiyoshi3, Shinya Kawashiri3, Naoki Iwamoto2, Kunihiro Ichinose4, Mami Tamai4, Tomoki Origuchi5, Hideki Nakamura2 and Atsushi Kawakami2, 1Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki City, Japan, 2Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 4Department of Immunology and Rheumatology, Unit of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Department of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

    Background/Purpose: Glycolysis is critical for T-cell effector functions, and increased glycolysis leads to autoimmunity. APT production by effector T cells is dependent on the mitochondria-independent…
  • Abstract Number: 140 • 2018 ACR/ARHP Annual Meeting

    Inhibition of Cathepsin S Leads to Suppression of SS-a/SS-B Specific T Cells from Patients with Primary Sjøgren Syndrome

    Patrick Hargreaves1,2, Michel Theron1, Fabrice Kolb1, Marianne Manchester1, Bernhard Reis1, Andre Tiaden2, Diego Kyburz2 and Tobias Manigold2, 1Hoffmann La Roche, Basel, Switzerland, 2Rheumatology, University Hospital Basel, Basel, Switzerland

    Background/Purpose: Primary Sjögren syndrome (pSS) is an autoimmune disease characterised by an infiltration of T and B cells into exocrine gland tissue and its subsequent…
  • Abstract Number: 141 • 2018 ACR/ARHP Annual Meeting

    Lymphocyte Activation Gene 3 Plasma Level Is Increased and Associated with Progression in Early Rheumatoid Arthritis

    Janni Maria Pedersen1,2,3, Aida Hansen4, Malene Hvid5, Kim Hørslev-Petersen6, Merete Lund Hetland7, Kristian Stengaard-Pedersen8, Mikkel Østergaard9, Bjarne Kuno Moeller10, Ellen-Margrethe Hauge11, Peter Junker12 and Bent Deleuran1,2, 1Department of Biomedicine, Aarhus University, Aarhus, Denmark, 2Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark, 4Biomedicine, Aarhus University, Aarhus, Denmark, 5Department of Clinical Medicine, Aarhus University, Aarhus, Denmark, 6King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark, 7University of Copenhagen, Copenhagen, Denmark, 8Department of Rheumatology, Aarhus University Hospital, Department of Clinical Medicine, Aarhus, Denmark, 9Center for Rheumatology and Spine Diseases, Rigshospitalet Glostrup Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 10Department of Immunology, Aarhus University Hospital, Aarhus, Denmark, 11Department of Rheumatology, Aarhus University Hospital, Aarhus, Aarhus, Denmark, 12Department of Rheumatology C, Odense University Hospital, Odense, Denmark

    Background/Purpose: Lymphocyte activation gene 3 (LAG3) resembles CD4 and is a key checkpoint molecule leading to downregulation of T cell proliferation and antigen presentation via…
  • Abstract Number: 142 • 2018 ACR/ARHP Annual Meeting

    Peripheral CD4+CD25+Foxp3+T Regulatory Cells Absolutely Reduce in Patients with Systemic Lupus Erythematosus

    Xiao-Qing Liu1, Na-Lin Lai2, Yanan Duan1, Junwei Chen1, Xiao-Feng Li3 and Chong Gao4, 1The Second Hospital of Shanxi Medical University, Taiyuan, China, 2Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China, 3Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China, 4Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA

    Background/Purpose: Regulatory T (Treg) cells, with the capacity to suppress immune responses, and effector T (Teff) cells, to promote inflammation, have been intensively studied in…
  • « Previous Page
  • 1
  • …
  • 1193
  • 1194
  • 1195
  • 1196
  • 1197
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology